AAAAAA
Results:
1-8
|
Results: 8
Authors:
PLUTCHIK L
SNYDER S
DROOKER M
CHODOFF L
SHEINER P
Citation: L. Plutchik et al., METHYLPHENIDATE IN POST LIVER-TRANSPLANT PATIENTS, Psychosomatics, 39(2), 1998, pp. 118-123
Authors:
MOR E
YUSSIM A
CHODOFF L
SCHWARTZ ME
Citation: E. Mor et al., NEW IMMUNOSUPPRESSIVE AGENTS FOR MAINTENANCE THERAPY IN ORGAN-TRANSPLANTATION - FOCUS ON ADVERSE-EFFECTS, Biodrugs, 8(6), 1997, pp. 469-488
Authors:
EMRE S
GENYK Y
KERN J
ALTACA G
GURKAN A
CHODOFF L
KIM L
GUY S
SHEINER P
SCHWARTZ M
MILLER CM
Citation: S. Emre et al., CONVERSION FROM TACROLIMUS TO CYCLOSPORINE IN LIVER RECIPIENTS - INDICATIONS AND RESULTS, Hepatology, 26(4), 1997, pp. 429-429
Authors:
PLUTCHIK LJ
SNYDER SL
DROOKER M
CHODOFF L
SHEINER P
Citation: Lj. Plutchik et al., METHYLPHENIDATE IN POSTOPERATIVE LIVER-TRANSPLANT PATIENTS, Psychosomatics, 38(2), 1997, pp. 36-36
Authors:
ISOLA L
CHODOFF L
SCIGLIANO E
VLACHOS A
FRUCHTMAN S
Citation: L. Isola et al., USE OF TACROLIMUS AS SALVAGE TREATMENT IN STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE, Blood, 88(10), 1996, pp. 3776-3776
Authors:
FISHER A
MOR E
HYTIROGLOU P
EMRE S
BOCCAGNI P
CHODOFF L
SHEINER P
SCHWARTZ M
THUNG SN
MILLER C
Citation: A. Fisher et al., FK506 HEPATOTOXICITY IN LIVER ALLOGRAFT RECIPIENTS, Transplantation, 59(11), 1995, pp. 1631-1632
Authors:
WOLF DC
FRENI MA
BOCCAGNI P
MOR E
CHODOFF L
SCHWARTZ ME
BODENHEIMER HC
Citation: Dc. Wolf et al., LOW-DOSE ASPIRIN THERAPY IS ASSOCIATED WITH A LOW-RATE OF SIDE-EFFECTS, BUT DOES NOT PREVENT HEPATIC-ARTERY THROMBOSIS IN LIVER-TRANSPLANT RECIPIENTS, Hepatology, 20(4), 1994, pp. 10000124-10000124
Authors:
SHEINER PA
MOR E
CHODOFF L
GLABMAN S
EMRE S
SCHWARTZ ME
MILLER CM
Citation: Pa. Sheiner et al., ACUTE RENAL, FAILURE ASSOCIATED WITH THE USE OF IBUPROFEN IN 2 LIVER-TRANSPLANT RECIPIENTS ON FK506, Transplantation, 57(7), 1994, pp. 1132-1133
Risultati:
1-8
|